CONFERENCE--CELLULAR IMMUNITY & IMMUNOTHERAPY OF CANCER

这是关于细胞免疫和癌症免疫治疗的Keystone研讨会系列会议的第四次会议。同样的组织者在1990年、1993年和1997年举行了前几次会议。这些会议是独一无二的，因为每一次会议都是衡量肿瘤免疫学进展的标尺。计划在未来两年举行的任何其他肿瘤免疫学会议都不会有这次会议通过Keystone研讨会会场确保的范围、广度和连续性。之前的三次会议展示了基础免疫学和相关领域的最新发展，这些领域可能会影响我们对肿瘤特异性免疫的理解。这次最新会议将以肿瘤免疫学方面的突破为特色，还将包括在抗原处理和呈递、T和B细胞激活、耐受性、记忆和凋亡以及它们与肿瘤特异性免疫相关的领域的最新发现。特别会议将专门讨论从传染病和自身免疫性疾病中吸取的经验教训。还将评估免疫治疗的最新临床方法。该计划旨在将研究基本免疫机制、病毒免疫和自身免疫的免疫学家与肿瘤免疫学家和免疫治疗师聚集在一起。与我们以往的会议一样，我们希望激发和鼓励激烈的讨论和思想的自由交流。我们特别注意邀请年轻的调查人员和妇女作为全体会议的发言者。在33位受邀发言者中，有7位是根据他们的出版物和/或在其他会议上令人印象深刻的发言而挑选出来的年轻调查人员。我们在项目中为更多的年轻研究人员预留了7个名额，他们将根据提交的摘要被选为简短的全体报告。

This is the fourth meeting in the series of Keystone Symposia on Cellular Immunity and Immunotherapy of Cancer. Previous meetings, by the same organizers, were held in 1990, 1993 and 1997. These meetings are unique because each one serves as a yard stick for measuring progress in tumor immunology. No other tumor immunology meeting that is planned for the next two years has the scope, the breadth and the continuity that this meeting ensures through the Keystone Symposia venue. The three previous meetings have featured the newest developments in basic immunology and related fields that could impact on our understanding of tumor-specific immunity. This latest meeting will feature breakthroughs in tumor immunology and will also include the most recent discoveries in the areas of antigen processing and presentation, T and B cell activation, tolerance, memory and apoptosis, and their relevance to tumor-specific immunity. A special session will be devoted to lessons learned from infectious and autoimmune diseases. The newest clinical approaches to immunotherapy will also be evaluated. The program is designed to bring immunologists working on basic immune mechanisms, viral immunity and autoimmunity together with tumor immunologists and immunotherapists. As in our previous meetings, we expect to provoke and encourage intense discussions and free flow of ideas. We have paid special attention to inviting young investigators and women as plenary session speakers. Of 33 invited speakers, 7 are young investigators selected based on their publications and/or impressive presentations at other meetings. We have reserved 7 slots in the program for additional young investigators who will be selected for short plenary presentations based on submitted abstracts.